[1] |
ZHANG Chi, CHEN Jiahui, LIN Jinyi, WANG Yan, ZHANG Sijia, ZHU Wei, CHENG Leilei.
Validation of a scale for evaluating the cardiovascular risk after breast cancer therapy: the clinical scale for breast cancer treatment related cardiovascular toxicity
[J]. China Oncology, 2022, 32(1): 54-60.
|
[2] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Targeting DNA damage response deficiency in the treatment of breast cancer
[J]. China Oncology, 2022, 32(1): 61-67.
|
[3] |
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) .
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
[J]. China Oncology, 2022, 32(1): 80-89.
|
[4] |
Tumor Support and Rehabilitation Therapy Group, the Oncology Committee of Chinese Medical Association.
Clinical practice guidelines for cancer-related fatigue in China (2021 edition)
[J]. China Oncology, 2021, 31(9): 852-872.
|
[5] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[6] |
ZHOU Hongyu , LI Haoran , CHENG Xi , CHEN Lihua , YANG Yufei , CHANG Bin .
Clinical characteristics of 11 patients with small cell carcinoma of the ovary, hypercalcemic type and literature review
[J]. China Oncology, 2021, 31(2): 136-142.
|
[7] |
LI Zeng , WU Yi , CHEN Zhuzhong , CHEN Li , LIAO Hong , MAO Dun , XIAO Yingming , XIE Hongping , LI Xiuli , YANG Shengke , ZHOU Shukui , ZHONG Lei , LU Hao , CHEN Yongji .
The value of 18 F-PSMA-1007 PET/CT in the early diagnosis and clinical treatment of patients with biochemical recurrence after radical prostatectomy
[J]. China Oncology, 2021, 31(11): 1081-1087.
|
[8] |
BAO Lingjie , NING Yan , YI Xiaofang .
Synchronous primary fallopian tube and endometrial cancers: a report of three cases and literature review
[J]. China Oncology, 2021, 31(10): 949-953.
|
[9] |
LIU Lucheng, YIN Bo.
Bilateral duplicate renal and ureteral malformation complicated with primary ureter squamous cell carcinoma: a case report
[J]. China Oncology, 2020, 30(4): 310-312.
|
[10] |
REN Yulan , LIN Jie , CHANG Bin , WANG Huaying .
Clinical analysis of 57 cases of primary female genital system lymphoma
[J]. China Oncology, 2020, 30(12): 1002-1007.
|
[11] |
WANG Jie .
Challenges and directions of immune checkpoint inhibitors in the treatment of lung cancer
[J]. China Oncology, 2020, 30(10): 744-749.
|
[12] |
WU Jia, ZHOU Jialiang.
The use of cetuximab in the continuum of care for patients with metastatic colorectal cancer
[J]. China Oncology, 2020, 30(1): 64-69.
|
[13] |
CHEN Jiaying, WANG Zhuoying.
Diagnosis and treatment progress of metastatic cervical carcinoma with an unknown primary
[J]. China Oncology, 2019, 29(6): 457-462.
|
[14] |
JIN Kaizhou, LUO Guopei, HUANG Qiuyi, et al.
The role of endoscopic ultrasound technique in the diagnosis and treatment of pancreatic adenocarcinoma
[J]. China Oncology, 2019, 29(1): 52-56.
|
[15] |
SONG Jianzhong, REN Wenhao, LI Shaoming, et al.
Retrospective analysis of surgical treatment in elderly patients (> 80 years) with oral and maxillofacial cancers
[J]. China Oncology, 2018, 28(4): 276-281.
|